AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Trial: 31957654
Drug: Cardiac rehabilitation
RxNorm normalized name: Leonurus cardiaca extract
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Cardiac rehabilitation (CR) for 6 months, including once weekly 90-minute in-facility exercise sessions and 4 days per week at-home exercise sessions.
Trial: 28144724
Drug: Nasal naloxone
RxNorm normalized name: naloxone Nasal Spray
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Nasal naloxone 0.8 mg
Trial: 28144724
Drug: Nasal naloxone
RxNorm normalized name: naloxone Nasal Spray
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Nasal naloxone 1.6 mg
Trial: 28144724
Drug: Intravenous naloxone
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Intravenous naloxone 1.0 mg
Trial: 22002479
Drug: Spontaneous clearance
RxNorm normalized name: salicylic acid
DrugBank: Salicylic acid (DB00936)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Spontaneous clearance (no treatment)
Trial: 17127224
Drug: Moxifloxacin 400
RxNorm normalized name: moxifloxacin 400 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Moxifloxacin 400 mg administered as a single dose in a 1 hour infusion (250 ml) for perioperative prophylaxis
Trial: 9388809
Drug: Treatment group
RxNorm normalized name: Hongo Killer Treatment
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Treatment group membership (collaborative recall task)
Trial: 28830881
Drug: Control group
RxNorm normalized name: meningococcal group B vaccine Prefilled Syringe [Trumenba]
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Control group (current dose for the first 12 months)
Trial: 26397083
Drug: Control group
RxNorm normalized name: meningococcal group B vaccine Prefilled Syringe [Trumenba]
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Control group (continued physical therapy)
Trial: 23357640
Drug: Mud therapy
RxNorm normalized name: Monistat Simple Therapy
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Mud therapy (11 consecutive sessions of peloids applied to the knee)
Trial: 23357640
Drug: Routine drug
RxNorm normalized name: Peace Out Acne Hero Routine KIT
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Routine drug treatment (Control group)
Trial: 11952546
Drug: Standard psoriasis
RxNorm normalized name: MG 217 Psoriasis
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Standard psoriasis treatment alone
Trial: 30658546
Drug: Manualised treatment
RxNorm normalized name: Hongo Killer Treatment
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Manualised treatment
Trial: 23757615
Drug: SITA/MET FDC
FDA approved: no
EMA approved: no
PMDA approved: no
Description: SITA/MET FDC 50/500 mg b.i.d. (uptitrated to 50/1,000 mg b.i.d.)
Trial: 23757615
Drug: MET 500
RxNorm normalized name: cefetamet 500 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: MET 500 mg b.i.d. (uptitrated to 1,000 mg b.i.d.)
Trial: 19628939
Drug: Music therapy
RxNorm normalized name: Monistat Simple Therapy
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Music therapy (weekly sessions of individual, receptive music therapy using the validated 'U' technique)
Trial: 17259554
Drug: Endocrine therapy
RxNorm normalized name: ENDOCRINE THERAPY
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Endocrine therapy combined with growth factor pathway inhibitors
Trial: 17259554
Drug: Selective estrogen
RxNorm normalized name: Selective estrogen receptor modulator
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Selective estrogen receptor modulator tamoxifen
Trial: 17259554
Drug: Pure ER
RxNorm normalized name: Dream Pure BB
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Pure ER antagonists
Trial: 15235928
Drug: Mizoribine (MZ)
RxNorm normalized name: Mizoribine
DrugBank: Mizoribine (DB12617)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Mizoribine (MZ) onlay therapy
Trial: 11763976
Drug: Oral administration
RxNorm normalized name: polidocanol
DrugBank: Polidocanol (DB06811)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Oral administration of 400 microg misoprostol, 8 h before aspiration
Trial: 11763976
Drug: Vaginal self‐administration
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Vaginal self‐administration of 400 microg misoprostol, 4 h before aspiration
Trial: 9409230
Drug: Omega-3 fatty
RxNorm normalized name: Omega-3 fatty acid
DrugBank: Omega-3 fatty acids (DB11133)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Omega-3 fatty acids (5 g eicosapentaenoic acid and docosahexaenoic acid per day)
Trial: 9409230
Drug: Antioxidants (75
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Antioxidants (75 mg vitamin E, 150 mg vitamin C, 15 mg beta-carotene, and 30 mg coenzyme Q10 per day)
Trial: 3321849
Drug: Cisapride (4
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Cisapride (4 mg, i.v. injection)
Trial: 27357095
Drug: Combination treatment
RxNorm normalized name: Hongo Killer Treatment
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Combination treatment (ZnC + colostrum)
Trial: 23311173
Drug: Traditional Chinese
RxNorm normalized name: BORNEOL 1 g in 6.5 g / MINT 1 g in 6.5 g / ANGELICA DAHURICA ROOT 0.5 g in 6.5 g TOPICAL POWDER [Traditional Chinese Medicine Health Card and TCM Epidemic Prevention Card]
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Traditional Chinese Medicines (Xiaozhi decoction), twice daily for 6 weeks
Trial: 23311173
Drug: Western medicine
RxNorm normalized name: Medicaine Sting
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Western medicine (0.5 g azithromycin for 3 days, 6 courses of treatment, each course lasting 4 days)
Trial: 20624316
Drug: 30-minute daily
RxNorm normalized name: lenvatinib
DrugBank: Lenvatinib (DB09078)
FDA approved: yes
EMA approved: yes
PMDA approved: yes
Description: 30-minute daily physical education sessions based on early psychomotor education
Trial: 20624316
Drug: 30-minute daily
RxNorm normalized name: lenvatinib
DrugBank: Lenvatinib (DB09078)
FDA approved: yes
EMA approved: yes
PMDA approved: yes
Description: 30-minute daily physical education sessions
Trial: 18179460
Drug: Flexible-dose sildenafil
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Flexible-dose sildenafil for ED treatment
Trial: 16565867
Drug: Telemedicine support
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Telemedicine support (Health Buddy computer providing daily Internet-based support)
Trial: 12037369
Drug: Experimental dentifrice
RxNorm normalized name: stannous fluoride
DrugBank: Stannous fluoride (DB11092)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Experimental dentifrice formulation containing stannous fluoride (SnF(2))
Trial: 12037369
Drug: Experimental dentifrice
RxNorm normalized name: stannous fluoride
DrugBank: Stannous fluoride (DB11092)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Experimental dentifrice formulation containing sodium fluoride (NaF)
Trial: 8573730
Drug: Manidipine (20
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Manidipine (20 mg/day)
Trial: 2128700
Drug: Requirement-adapted peripheral-venous
RxNorm normalized name: bushmaster venom
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Requirement-adapted peripheral-venous parenteral nutrition with maltose and fat emulsion (650 mosm/l; 2,000 kcal)
Trial: 2128700
Drug: Common requirement-adapted
RxNorm normalized name: Common carp
DrugBank: Common carp (DB10614)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Common requirement-adapted parenteral nutrition regimen via central-venous catheter (2,000 mosm/l; 2,000 kcal)
Trial: 29173735
Drug: Lurasidone 20
RxNorm normalized name: lurasidone 20 mg oral tablet
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Lurasidone 20 to 80 mg/day
Trial: 25500487
Drug: canagliflozin (all
FDA approved: no
EMA approved: no
PMDA approved: no
Description: canagliflozin (all doses)
Trial: 17153881
Drug: Beta-glucuronidase (BG)
RxNorm normalized name: Recombinant human beta-glucuronidase
DrugBank: Vestronidase alfa (DB12366)
FDA approved: yes
EMA approved: yes
PMDA approved: yes
Description: Beta-glucuronidase (BG) treatment
Trial: 11185629
Drug: Oral administration
RxNorm normalized name: polidocanol
DrugBank: Polidocanol (DB06811)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Oral administration of [14C]telmisartan 40 mg
Trial: 11185629
Drug: Intravenous infusion
RxNorm normalized name: intravenous infusion pump accessory
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Intravenous infusion of [14C]telmisartan 40 mg
Trial: 11185629
Drug: Both oral
RxNorm normalized name: Bothrops atrox venom
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Both oral and intravenous administration
Trial: 6434117
Drug: Low dose
RxNorm normalized name: Low Dose ASA
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Low dose antacid (10 ml as required)
Trial: 6434117
Drug: Low dose
RxNorm normalized name: Low Dose ASA
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Low dose placebo
Trial: 6434117
Drug: High dose
RxNorm normalized name: INFLUENZA VACCINE HIGH DOSE 0.5ML SYR
FDA approved: no
EMA approved: no
PMDA approved: no
Description: High dose antacid (30 ml seven times daily)
Trial: 6434117
Drug: High dose
RxNorm normalized name: INFLUENZA VACCINE HIGH DOSE 0.5ML SYR
FDA approved: no
EMA approved: no
PMDA approved: no
Description: High dose placebo
Trial: 27085660
Drug: Carotid Endarterectomy
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Carotid Endarterectomy (CEA) plus Best Medical Treatment (BMT)
Trial: 27085660
Drug: Carotid Artery
RxNorm normalized name: Sus scrofa artery preparation
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Carotid Artery Stenting (CAS) plus Best Medical Treatment (BMT)
Trial: 27085660
Drug: Best Medical
RxNorm normalized name: calcium polycarbophil
DrugBank: Calcium polycarbophil (DB14684)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Best Medical Treatment (BMT) alone
Trial: 7612715
Drug: Oral feeding
RxNorm normalized name: SET,FEEDING
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Oral feeding ad libitum (control group)
Trial: 29741754
Drug: Probiotics (2
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Probiotics (2 capsules of Lactobacillus rhamnosus GG daily for 6 months)
Trial: 26674898
Drug: 1 g
RxNorm normalized name: Molds 1 g
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 1 g (2 × 500 mg) tranexamic acid tablets before surgery
Trial: 25140000
Drug: First-line chemotherapy
RxNorm normalized name: ethanol
DrugBank: Ethanol (DB00898)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: First-line chemotherapy combined with bevacizumab
Trial: 18626295
Drug: Cognitive-behavioral therapy
RxNorm normalized name: Monistat Simple Therapy
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Cognitive-behavioral therapy (CBT) + imipramine
Trial: 18626295
Drug: Cognitive-behavioral therapy
RxNorm normalized name: Monistat Simple Therapy
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Cognitive-behavioral therapy (CBT) + placebo
Trial: 8965037
Drug: Topical steroid
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Topical steroid injection
Trial: 8965037
Drug: Deltoid muscle
RxNorm normalized name: ActivOn Joint & Muscle
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Deltoid muscle injection
Trial: 1743321
Drug: 5 micrograms
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 5 micrograms GnRH pulse dose
Trial: 1743321
Drug: 10 micrograms
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 10 micrograms GnRH pulse dose
Trial: 1743321
Drug: 20 micrograms
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 20 micrograms GnRH pulse dose
Trial: 30586746
Drug: ALD-401 infusion
RxNorm normalized name: Duo Fusion
DrugBank: Magnesium hydroxide (DB09104)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: ALD-401 infusion
Trial: 29070115
Drug: High-dose methotrexate
FDA approved: no
EMA approved: no
PMDA approved: no
Description: High-dose methotrexate combined with rituxan (targeted treatment group)
Trial: 29070115
Drug: High-dose methotrexate
FDA approved: no
EMA approved: no
PMDA approved: no
Description: High-dose methotrexate combined with whole brain radiotherapy (traditional treatment group)
Trial: 26091461
Drug: Dexmedetomidine (DEX)
DrugBank: Dexmedetomidine (DB00633)
FDA approved: yes
EMA approved: no
PMDA approved: yes
Description: Dexmedetomidine (DEX) administered at a loading dose of 0.5 μg/kg for 10 minutes, followed by an infusion rate of 0.4 μg/kg/h from insufflation of the pneumoperitoneum to the end of surgery.
Trial: 26091461
Drug: Dexmedetomidine (DEX)
DrugBank: Dexmedetomidine (DB00633)
FDA approved: yes
EMA approved: no
PMDA approved: yes
Description: Dexmedetomidine (DEX) administered as described above.
Trial: 23512419
Drug: Morphine 0.04
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Morphine 0.04 mg/kg iv followed by 0.01 mg/kg/h infusion for 24 h
Trial: 19893121
Drug: Filgrastim (Neupogen)
RxNorm normalized name: Filgrastim
DrugBank: Filgrastim (DB00099)
FDA approved: yes
EMA approved: yes
PMDA approved: yes
Description: Filgrastim (Neupogen) administered systematically during antiviral therapy
Trial: 19893121
Drug: Combination antiviral
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Combination antiviral therapy (pegylated interferon alfa plus ribavirin) without Filgrastim
Trial: 17536485
Drug: Basal diet
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Basal diet supplemented with 9.05 mmol (220 mg) magnesium/d for 72 d
Trial: 15449150
Drug: UFT 600
RxNorm normalized name: UFT
DrugBank: Tegafur-uracil (DB09327)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: UFT 600 mg/day preoperatively for 7 consecutive days
Trial: 8988721
Drug: Control group
RxNorm normalized name: meningococcal group B vaccine Prefilled Syringe [Trumenba]
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Control group (no chemotherapy or radiotherapy)
Trial: 9684137
Drug: Prolonged PPC
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Prolonged PPC therapy
Trial: 2541967
Drug: Treated capsules
RxNorm normalized name: benzoyl peroxide
DrugBank: Benzoyl peroxide (DB09096)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Treated capsules (Nonoxynol-9)
Trial: 2541967
Drug: Non-treated capsules
RxNorm normalized name: Tavist Non-Sedating
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Non-treated capsules (Nonoxynol-9)
Trial: 29607658
Drug: Presence of
RxNorm normalized name: Dna Plasmid Expressing Diphtheria Toxin Triggered By The Presence Of Oncofetal Gene H19
DrugBank: Inodiftagene vixteplasmid (DB16017)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Presence of none of the conditions (mental illness, hazardous alcohol use, drug dependence)
Trial: 29607658
Drug: Presence of
RxNorm normalized name: Dna Plasmid Expressing Diphtheria Toxin Triggered By The Presence Of Oncofetal Gene H19
DrugBank: Inodiftagene vixteplasmid (DB16017)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Presence of all three conditions (mental illness, hazardous alcohol use, drug dependence)
Trial: 16231766
Drug: 25 microg
RxNorm normalized name: Digoxin 125 microgram oral tablet
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 25 microg x h(‐1) fentanyl and 4 mg x h(‐1) ketamine
Trial: 16231766
Drug: 35 microg
RxNorm normalized name: Ethinyl estradiol 35 microgram and norethindrone 1 mg oral tablet
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 35 microg x h(‐1) subcutaneous fentanyl infusion
Trial: 16231766
Drug: 50 microg
RxNorm normalized name: Digoxin 250 microgram oral tablet
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 50 microg x h(‐1) subcutaneous fentanyl infusion
Trial: 16231766
Drug: 25 microg
RxNorm normalized name: Digoxin 125 microgram oral tablet
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 25 microg x h(‐1) fentanyl and 2 mg x h(‐1) ketamine
Trial: 12220322
Drug: Carbamazepine (placebo
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Carbamazepine (placebo add-on treatment)
Trial: 1969567
Drug: Antihypertensive drugs
RxNorm normalized name: ANTIHYPERTENSIVES
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Antihypertensive drugs (diuretics or beta-blockers)
Trial: 7026258
Drug: Paracetamol (1000
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Paracetamol (1000 mg i.v.)
Trial: 28578427
Drug: 2.0 g
RxNorm normalized name: Fifty50 2.0 Glucose Meter
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 2.0 g glutamine administration
Trial: 23648352
Drug: Treatment for
RxNorm normalized name: Hair Regrowth Treatment For Men
DrugBank: Minoxidil (DB00350)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Treatment for elevated serum muscle enzymes in HP patients
Trial: 21849260
Drug: Carisbamate 1000
RxNorm normalized name: Chlorphenesin Carbamate
DrugBank: Chlorphenesin carbamate (DB14656)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Carisbamate 1000 mg/day
Trial: 21849260
Drug: Carisbamate 1500
RxNorm normalized name: Chlorphenesin Carbamate
DrugBank: Chlorphenesin carbamate (DB14656)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Carisbamate 1500 mg/day
Trial: 21849260
Drug: Carisbamate (<1000
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Carisbamate (<1000 mg/day)
Trial: 17245623
Drug: Imatinib mesylate
RxNorm normalized name: Imatinib Mesylate
DrugBank: Imatinib (DB00619)
FDA approved: yes
EMA approved: yes
PMDA approved: no
Description: Imatinib mesylate plus hydroxyurea (500 mg twice a day)
Trial: 11191092
Drug: Desogestrel (150
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Desogestrel (150 microg orally daily) and testosterone pellets (2 x 200 mg per 12 weeks)
Trial: 11191092
Drug: Desogestrel (150
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Desogestrel (150 microg orally daily) and testosterone pellets (2 x 200 mg per 12 weeks) with finasteride (5 mg orally daily)
Trial: 9682338
Drug: DTP +
RxNorm normalized name: DTP-348
DrugBank: DTP-348 (DB12741)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: DTP + PRP-T administered in separate injections (S-In group, n = 237)
Trial: 7982415
Drug: Intravenous magnesium
RxNorm normalized name: immunoglobulins, intravenous
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Intravenous magnesium sulphate (46-52 mmol/18-20 h)
Trial: 7982415
Drug: Oral magnesium
RxNorm normalized name: Oral Film
DrugBank: Sodium citrate (DB09154)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Oral magnesium hydroxide (600 mg/day)
Trial: 26457893
Drug: Interactive group
RxNorm normalized name: Streptococcus viridans group
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Interactive group music therapy (n = 62; 20 units of 40 minutes, 2×/week)
Trial: 26077620
Drug: Telephone Cognitive
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Telephone Cognitive Behavioral Therapy (T‐CBT)
Trial: 26077620
Drug: Treatment delivery
RxNorm normalized name: Hongo Killer Treatment
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Treatment delivery method (T‐CBT vs FtF‐CBT)
Trial: 18353632
Drug: Recent treatment
RxNorm normalized name: Hongo Killer Treatment
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Recent treatment protocols with higher cumulative doses or increased dose intensity of alkylators and epipodophyllotoxins and the use of G-CSF
Trial: 18353632
Drug: Earlier treatment
RxNorm normalized name: Hongo Killer Treatment
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Earlier treatment protocols
Trial: 18353632
Drug: Overall treatment
RxNorm normalized name: Hongo Killer Treatment
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Overall treatment for ESFT
Trial: 12620695
Drug: Prior antihypertensive
RxNorm normalized name: Priorix
DrugBank: Rubella virus vaccine (DB10317)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Prior antihypertensive treatment
Trial: 11137246
Drug: High-dose hepatitis
FDA approved: no
EMA approved: no
PMDA approved: no
Description: High-dose hepatitis A and B vaccine (2 doses at month 0 and 6)
Trial: 11137246
Drug: Twinrix (3
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Twinrix (3 doses at month 0, 1, and 6)
Trial: 11137246
Drug: High-dose hepatitis
FDA approved: no
EMA approved: no
PMDA approved: no
Description: High-dose hepatitis A and B vaccine
Trial: 8482290
Drug: Long prednisone
RxNorm normalized name: Prednisone
DrugBank: Prednisone acetate (DB14646)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Long prednisone therapy (60 mg/m2 per 24 h for 6 weeks, followed by alternate day 40 mg/m2 per 48 h for 6 weeks)
Trial: 8482290
Drug: Standard prednisone
RxNorm normalized name: Prednisone
DrugBank: Prednisone acetate (DB14646)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Standard prednisone therapy (60 mg/m2 per 24 h for 4 weeks, followed by 40 mg/m2 per 48 h for 4 weeks)
Trial: 8482290
Drug: Long prednisone
RxNorm normalized name: Prednisone
DrugBank: Prednisone acetate (DB14646)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Long prednisone therapy
Trial: 3434601
Drug: Models administration
RxNorm normalized name: polidocanol
DrugBank: Polidocanol (DB06811)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Models administration of three-dimensional constructional praxis tests
Trial: 3434601
Drug: Photographs administration
RxNorm normalized name: polidocanol
DrugBank: Polidocanol (DB06811)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Photographs administration of three-dimensional constructional praxis tests
Trial: 3434601
Drug: Drawings administration
RxNorm normalized name: polidocanol
DrugBank: Polidocanol (DB06811)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Drawings administration of three-dimensional constructional praxis tests
Trial: 29306481
Drug: Standard treatment
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Standard treatment + 25(OH)D3 supplementation
Trial: 29306481
Drug: Patients with
RxNorm normalized name: Primatene with ephedrine Pill
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Patients with 25(OH)D levels ≤ 50 nmol/L
Trial: 29306481
Drug: Patients with
RxNorm normalized name: Primatene with ephedrine Pill
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Patients with 25(OH)D levels > 50 nmol/L
Trial: 26685099
Drug: Oral sucrose
RxNorm normalized name: TootSweet 24% Oral Sucrose Solution
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Oral sucrose combined with NNS (group NS)
Trial: 26685099
Drug: Oral sucrose
RxNorm normalized name: TootSweet 24% Oral Sucrose Solution
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Oral sucrose combined with swaddling (group SS)
Trial: 26685099
Drug: Oral sucrose
RxNorm normalized name: TootSweet 24% Oral Sucrose Solution
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Oral sucrose combined with NNS and swaddling (group NSS)
Trial: 26685099
Drug: Oral sucrose
RxNorm normalized name: TootSweet 24% Oral Sucrose Solution
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Oral sucrose (routine care, group S)